Skip to main content
Top
Published in: BMC Infectious Diseases 1/2014

Open Access 01-12-2014 | Case report

Dissemination of multidrug-resistant tuberculosis in a patient with acute HIV infection

Authors: Kyung Mo Yoo, Eun-Jeong Joo, Joon-Sup Yeom, Seoung-Wan Chae, Shin Yeoung Lee, Ki Joong Han

Published in: BMC Infectious Diseases | Issue 1/2014

Login to get access

Abstract

Background

Opportunistic infections are relatively rare in early human immunodeficiency virus infection, especially infection with Mycobacterium tuberculosis. Here, we report a patient who presented with acute human immunodeficiency virus and multidrug-resistant M. tuberculosis co-infections.

Case presentation

A 27-year-old homosexual male was admitted for fever, cough, and hepatitis. At the time of admission, the p24 antigen was detected in his serum, indicating that he had an acute human immunodeficiency virus infection. He was also diagnosed with disseminated tuberculosis spreading to the lung and skin. Anti-tuberculosis medication had been started earlier with one-week intervals of highly active antiretroviral therapy. Despite prolonged anti-tuberculosis treatment, the patient developed tuberculous meningitis on the 50th day of admission. Multidrug-resistant tuberculosis was cultured from his sputum and cerebrospinal fluid. The patient was successfully treated with second line anti-tuberculosis medication and antiretroviral treatment.

Conclusion

This is the first case of acute human immunodeficiency virus and multi drug-resistance tuberculosis co-infections. This case indicates that tuberculosis infection should be considered even in patients with acute human immunodeficiency virus infection.
Appendix
Available only for authorised users
Literature
1.
go back to reference Sued O, Quiroga MF, Socias ME, Turk G, Salomon H, Cahn P: Acute HIV seroconversion presenting with active tuberculosis and associated with high levels of T-regulatory cells. Viral Immunol. 2011, 24: 347-349. 10.1089/vim.2010.0101.CrossRefPubMedPubMedCentral Sued O, Quiroga MF, Socias ME, Turk G, Salomon H, Cahn P: Acute HIV seroconversion presenting with active tuberculosis and associated with high levels of T-regulatory cells. Viral Immunol. 2011, 24: 347-349. 10.1089/vim.2010.0101.CrossRefPubMedPubMedCentral
2.
go back to reference Kim SJ: Drug-susceptibility testing in tuberculosis: methods and reliability of results. Eur Respir J. 2005, 25: 564-569. 10.1183/09031936.05.00111304.CrossRefPubMed Kim SJ: Drug-susceptibility testing in tuberculosis: methods and reliability of results. Eur Respir J. 2005, 25: 564-569. 10.1183/09031936.05.00111304.CrossRefPubMed
3.
go back to reference Wayne P: Clinical and Laboratory Standards Institute (CLSI): Susceptibility Testing of Mycobacteria, Nocardiae, and Other Aerobic Actinomycetes; Approved Standard— Second. M24-A2 edition. Susceptibility Testing of Mycobacterium, Nocardiae, and other Aerobic Actinomycetes; Approved Standard-Second Edition. 2011, Wayne, PA, USA: Clinical and Laboratory Standards Institute Wayne P: Clinical and Laboratory Standards Institute (CLSI): Susceptibility Testing of Mycobacteria, Nocardiae, and Other Aerobic Actinomycetes; Approved Standard— Second. M24-A2 edition. Susceptibility Testing of Mycobacterium, Nocardiae, and other Aerobic Actinomycetes; Approved Standard-Second Edition. 2011, Wayne, PA, USA: Clinical and Laboratory Standards Institute
5.
go back to reference Sued O, Miro JM, Alquezar A, Claramonte X, Garcia F, Plana M, Arnedo M, de Lazzari E, Gil C, Manzardo C, Blanco JL, Martínez E, Mallolas J, Joseph J, Pumarola T, Gallart T, Gatell JM: Primary human immunodeficiency virus type 1 infection: clinical, virological and immunological characteristics of 75 patients (1997–2003). Enferm Infecc Microbiol Clin. 2006, 24: 238-244. 10.1016/S0213-005X(06)73769-7.CrossRefPubMed Sued O, Miro JM, Alquezar A, Claramonte X, Garcia F, Plana M, Arnedo M, de Lazzari E, Gil C, Manzardo C, Blanco JL, Martínez E, Mallolas J, Joseph J, Pumarola T, Gallart T, Gatell JM: Primary human immunodeficiency virus type 1 infection: clinical, virological and immunological characteristics of 75 patients (1997–2003). Enferm Infecc Microbiol Clin. 2006, 24: 238-244. 10.1016/S0213-005X(06)73769-7.CrossRefPubMed
6.
go back to reference Pena JM, Martinez-Lopez MA, Arnalich F, Barbado FJ, Vazquez JJ: Esophageal candidiasis associated with acute infection due to human immunodeficiency virus: case report and review. Rev Infect Dis. 1991, 13: 872-875. 10.1093/clinids/13.5.872.CrossRefPubMed Pena JM, Martinez-Lopez MA, Arnalich F, Barbado FJ, Vazquez JJ: Esophageal candidiasis associated with acute infection due to human immunodeficiency virus: case report and review. Rev Infect Dis. 1991, 13: 872-875. 10.1093/clinids/13.5.872.CrossRefPubMed
7.
go back to reference Hong KW, Kim SI, Kim YJ, Wie SH, Kim YR, Yoo JH, Han NI, Kang MW: Acute cytomegalovirus pneumonia and hepatitis presenting during acute HIV retroviral syndrome. Infection. 2011, 39: 155-159. 10.1007/s15010-010-0074-4.CrossRefPubMed Hong KW, Kim SI, Kim YJ, Wie SH, Kim YR, Yoo JH, Han NI, Kang MW: Acute cytomegalovirus pneumonia and hepatitis presenting during acute HIV retroviral syndrome. Infection. 2011, 39: 155-159. 10.1007/s15010-010-0074-4.CrossRefPubMed
8.
go back to reference Moss PJ, Read RC, Kudesia G, McKendrick MW: Prolonged cryptosporidiosis during primary HIV infection. J Infect. 1995, 30: 51-53. 10.1016/S0163-4453(95)92873-1.CrossRefPubMed Moss PJ, Read RC, Kudesia G, McKendrick MW: Prolonged cryptosporidiosis during primary HIV infection. J Infect. 1995, 30: 51-53. 10.1016/S0163-4453(95)92873-1.CrossRefPubMed
9.
go back to reference Silva Mde O, Bastos M, Netto EM, Gouvea NA, Torres AJ, Kallas E, Watkins DI, Altfeld M, Brites C: Acute HIV infection with rapid progression to AIDS. Braz J Infect Dis. 2010, 14: 291-293. 10.1016/S1413-8670(10)70059-3.CrossRefPubMed Silva Mde O, Bastos M, Netto EM, Gouvea NA, Torres AJ, Kallas E, Watkins DI, Altfeld M, Brites C: Acute HIV infection with rapid progression to AIDS. Braz J Infect Dis. 2010, 14: 291-293. 10.1016/S1413-8670(10)70059-3.CrossRefPubMed
10.
go back to reference Signorini L, Gulletta M, Coppini D, Donzelli C, Stellini R, Manca N, Carosi G, Matteelli A: Fatal disseminated toxoplasmosis during primary HIV infection. Curr HIV Res. 2007, 5: 273-274. 10.2174/157016207780077011.CrossRefPubMed Signorini L, Gulletta M, Coppini D, Donzelli C, Stellini R, Manca N, Carosi G, Matteelli A: Fatal disseminated toxoplasmosis during primary HIV infection. Curr HIV Res. 2007, 5: 273-274. 10.2174/157016207780077011.CrossRefPubMed
11.
go back to reference Vento S, Di Perri G, Garofano T, Concia E, Bassetti D: Pneumocystis carinii pneumonia during primary HIV-1 infection. Lancet. 1993, 342: 24-25. 10.1016/0140-6736(93)91884-O.CrossRefPubMed Vento S, Di Perri G, Garofano T, Concia E, Bassetti D: Pneumocystis carinii pneumonia during primary HIV-1 infection. Lancet. 1993, 342: 24-25. 10.1016/0140-6736(93)91884-O.CrossRefPubMed
12.
go back to reference Joh JS, Lee CH, Lee JE, Park YK, Bai GH, Kim EC, Han SK, Shim YS, Yim JJ: The interval between initiation of anti-tuberculosis treatment in patients with culture-positive pulmonary tuberculosis and receipt of drug-susceptibility test results. J Korean Med Sci. 2007, 22: 26-29. 10.3346/jkms.2007.22.1.26.CrossRefPubMedPubMedCentral Joh JS, Lee CH, Lee JE, Park YK, Bai GH, Kim EC, Han SK, Shim YS, Yim JJ: The interval between initiation of anti-tuberculosis treatment in patients with culture-positive pulmonary tuberculosis and receipt of drug-susceptibility test results. J Korean Med Sci. 2007, 22: 26-29. 10.3346/jkms.2007.22.1.26.CrossRefPubMedPubMedCentral
13.
go back to reference Huyen MN, Tiemersma EW, Lan NT, Cobelens FG, Dung NH, Sy DN, Buu TN, Kremer K, Hang PT, Caws M, O'Brien R, van Soolingen D: Validation of the GenoType MTBDRplus assay for diagnosis of multidrug resistant tuberculosis in South Vietnam. BMC Infect Dis. 2010, 10: 149-10.1186/1471-2334-10-149.CrossRefPubMedPubMedCentral Huyen MN, Tiemersma EW, Lan NT, Cobelens FG, Dung NH, Sy DN, Buu TN, Kremer K, Hang PT, Caws M, O'Brien R, van Soolingen D: Validation of the GenoType MTBDRplus assay for diagnosis of multidrug resistant tuberculosis in South Vietnam. BMC Infect Dis. 2010, 10: 149-10.1186/1471-2334-10-149.CrossRefPubMedPubMedCentral
14.
go back to reference Jenkins HE, Crudu V, Soltan V, Ciobanu A, Domente L, Cohen T: High risk and rapid appearance of multidrug resistance during tuberculosis treatment in Moldova. Eur Respir J. 2014, 43: 1132-1141. 10.1183/09031936.00203613.CrossRefPubMedPubMedCentral Jenkins HE, Crudu V, Soltan V, Ciobanu A, Domente L, Cohen T: High risk and rapid appearance of multidrug resistance during tuberculosis treatment in Moldova. Eur Respir J. 2014, 43: 1132-1141. 10.1183/09031936.00203613.CrossRefPubMedPubMedCentral
15.
go back to reference Merker M, Kohl TA, Roetzer A, Truebe L, Richter E, Rusch-Gerdes S, Fattorini L, Oggioni MR, Cox H, Varaine F, Niemann S: Whole genome sequencing reveals complex evolution patterns of multidrug-resistant Mycobacterium tuberculosis Beijing strains in patients. PLoS One. 2013, 8: e82551-10.1371/journal.pone.0082551.CrossRefPubMedPubMedCentral Merker M, Kohl TA, Roetzer A, Truebe L, Richter E, Rusch-Gerdes S, Fattorini L, Oggioni MR, Cox H, Varaine F, Niemann S: Whole genome sequencing reveals complex evolution patterns of multidrug-resistant Mycobacterium tuberculosis Beijing strains in patients. PLoS One. 2013, 8: e82551-10.1371/journal.pone.0082551.CrossRefPubMedPubMedCentral
16.
go back to reference Saunders NJ, Trivedi UH, Thomson ML, Doig C, Laurenson IF, Blaxter ML: Deep resequencing of serial sputum isolates of Mycobacterium tuberculosis during therapeutic failure due to poor compliance reveals stepwise mutation of key resistance genes on an otherwise stable genetic background. J Infect. 2011, 62: 212-217. 10.1016/j.jinf.2011.01.003.CrossRefPubMed Saunders NJ, Trivedi UH, Thomson ML, Doig C, Laurenson IF, Blaxter ML: Deep resequencing of serial sputum isolates of Mycobacterium tuberculosis during therapeutic failure due to poor compliance reveals stepwise mutation of key resistance genes on an otherwise stable genetic background. J Infect. 2011, 62: 212-217. 10.1016/j.jinf.2011.01.003.CrossRefPubMed
17.
go back to reference Pawlowski A, Jansson M, Skold M, Rottenberg ME, Kallenius G: Tuberculosis and HIV co-infection. PLoS Pathog. 2012, 8: e1002464-10.1371/journal.ppat.1002464.CrossRefPubMedPubMedCentral Pawlowski A, Jansson M, Skold M, Rottenberg ME, Kallenius G: Tuberculosis and HIV co-infection. PLoS Pathog. 2012, 8: e1002464-10.1371/journal.ppat.1002464.CrossRefPubMedPubMedCentral
18.
go back to reference Gandhi NR, Andrews JR, Brust JC, Montreuil R, Weissman D, Heo M, Moll AP, Friedland GH, Shah NS: Risk factors for mortality among MDR- and XDR-TB patients in a high HIV prevalence setting. Int J Tuberc Lung Dis. 2012, 16: 90-97. 10.5588/ijtld.11.0153.CrossRefPubMedPubMedCentral Gandhi NR, Andrews JR, Brust JC, Montreuil R, Weissman D, Heo M, Moll AP, Friedland GH, Shah NS: Risk factors for mortality among MDR- and XDR-TB patients in a high HIV prevalence setting. Int J Tuberc Lung Dis. 2012, 16: 90-97. 10.5588/ijtld.11.0153.CrossRefPubMedPubMedCentral
19.
go back to reference Mesfin YM, Hailemariam D, Biadglign S, Kibret KT: Association between HIV/AIDS and multi-drug resistance tuberculosis: a systematic review and meta-analysis. PLoS One. 2014, 9: e82235-10.1371/journal.pone.0082235.CrossRefPubMedPubMedCentral Mesfin YM, Hailemariam D, Biadglign S, Kibret KT: Association between HIV/AIDS and multi-drug resistance tuberculosis: a systematic review and meta-analysis. PLoS One. 2014, 9: e82235-10.1371/journal.pone.0082235.CrossRefPubMedPubMedCentral
20.
go back to reference Naing C, Mak JW, Maung M, Wong SF, Kassim AI: Meta-analysis: the association between HIV infection and extrapulmonary tuberculosis. Lung. 2013, 191: 27-34. 10.1007/s00408-012-9440-6.CrossRefPubMed Naing C, Mak JW, Maung M, Wong SF, Kassim AI: Meta-analysis: the association between HIV infection and extrapulmonary tuberculosis. Lung. 2013, 191: 27-34. 10.1007/s00408-012-9440-6.CrossRefPubMed
21.
go back to reference Geldmacher C, Zumla A, Hoelscher M: Interaction between HIV and Mycobacterium tuberculosis: HIV-1-induced CD4 T-cell depletion and the development of active tuberculosis. Curr Opin HIV AIDS. 2012, 7: 268-275.PubMed Geldmacher C, Zumla A, Hoelscher M: Interaction between HIV and Mycobacterium tuberculosis: HIV-1-induced CD4 T-cell depletion and the development of active tuberculosis. Curr Opin HIV AIDS. 2012, 7: 268-275.PubMed
22.
go back to reference Byers DK, Decker CF: Unusual case of Pneumocystis jiroveci pneumonia during primary HIV infection. AIDS Read. 2008, 18: 313-317.PubMed Byers DK, Decker CF: Unusual case of Pneumocystis jiroveci pneumonia during primary HIV infection. AIDS Read. 2008, 18: 313-317.PubMed
24.
go back to reference Wells CD, Cegielski JP, Nelson LJ, Laserson KF, Holtz TH, Finlay A, Castro KG, Weyer K: HIV infection and multidrug-resistant tuberculosis: the perfect storm. J Infect Dis. 2007, 196 (Suppl 1): S86-107.CrossRefPubMed Wells CD, Cegielski JP, Nelson LJ, Laserson KF, Holtz TH, Finlay A, Castro KG, Weyer K: HIV infection and multidrug-resistant tuberculosis: the perfect storm. J Infect Dis. 2007, 196 (Suppl 1): S86-107.CrossRefPubMed
Metadata
Title
Dissemination of multidrug-resistant tuberculosis in a patient with acute HIV infection
Authors
Kyung Mo Yoo
Eun-Jeong Joo
Joon-Sup Yeom
Seoung-Wan Chae
Shin Yeoung Lee
Ki Joong Han
Publication date
01-12-2014
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2014
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/1471-2334-14-462

Other articles of this Issue 1/2014

BMC Infectious Diseases 1/2014 Go to the issue

Reviewer acknowledgement

Reviewer acknowledgement 2013

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.